2C-CPe
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
2C-CPe, also known as 4-cyclopentyl-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024. It is a moderately potent agonist at the serotonin receptor 5-HT 2A in vitro, with a binding affinity (K i ) of 134 nM, slightly weaker than the related cyclopropyl compound 2C-CP. It is not known to have been tested in humans or animals. It is a controlled substance in Canada under phenethylamine blanket-ban language.
2C-CPe, also known as 4-cyclopentyl-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024. It is a moderately potent agonist at the serotonin receptor 5-HT 2A in vitro, with a binding affinity (K i ) of 134 nM, slightly weaker than the related cyclopropyl compound 2C-CP. It is not known to have been tested in humans or animals. It is a controlled substance in Canada under phenethylamine blanket-ban language.
See also
2C (psychedelics) 2C-P 2C-Bu 2C-iBu
References
External links
2C-CPe - Isomer Design
Text derived from https://en.wikipedia.org/w/index.php?oldid=1371213087 under CC BY-SA 4.0; modifications have been made.